We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.32%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KALV
2251
DELISTED
KalVista Pharmaceuticals
KALV
$1.32M ﹤0.01%
133,687
+97,328
+268% +$1.07M
ISEE
2252
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.32M ﹤0.01%
+136,875
New +$1.72M
CMRX
2253
DELISTED
Chimerix, Inc.
CMRX
$1.31M ﹤0.01%
+631,560
New +$2.03M
MCY icon
2254
Mercury Insurance
MCY
$5.87B
$1.31M ﹤0.01%
+29,610
New +$1.46M
SGII
2255
DELISTED
Seaport Global Acquisition II Corp. Class A Common Stock
SGII
$1.31M ﹤0.01%
131,313
+7,970
+6% +$79.2K
CRU.WS
2256
CALL
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$1.31M ﹤0.01%
133,328
DHBCW
2257
CALL
DELISTED
DHB Capital Corp. Warrant
DHBCW
$1.31M ﹤0.01%
133,732
+404
+0.3% +$81
TR icon
2258
Tootsie Roll Industries
TR
$2.94B
$1.31M ﹤0.01%
41,674
-3,538
-8% -$107K
WAVC.WS
2259
CALL
DELISTED
Waverley Capital Acquisition Corp. 1 Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
WAVC.WS
$1.31M ﹤0.01%
135,095
CORT icon
2260
Corcept Therapeutics
CORT
$12.2B
$1.31M ﹤0.01%
+54,968
New +$1.2M
AFCG
2261
AFC Gamma
AFCG
$64.1M
$1.3M ﹤0.01%
123,859
+38,157
+45% +$447K
VOYA icon
2262
Voya Financial
VOYA
$9.02B
$1.29M ﹤0.01%
+21,712
New +$1.4M
PRENW
2263
CALL
Prenetics Global Ltd Warrant
PRENW
$130K
$1.29M ﹤0.01%
+320,000
New +$119K
DASH icon
2264
DoorDash
DASH
$92.6B
$1.29M ﹤0.01%
20,100
-191,229
-90% -$15.2M
FTPAW
2265
CALL
DELISTED
FTAC Parnassus Acquisition Corp. Warrant
FTPAW
$1.29M ﹤0.01%
130,864
GOTU icon
2266
Gaotu Techedu
GOTU
$432M
$1.29M ﹤0.01%
657,070
+577,866
+730% +$927K
HTT
2267
High Templar Tech Ltd
HTT
$391M
$1.29M ﹤0.01%
1,169,794
-258,733
-18% -$252K
RNAC icon
2268
Cartesian Therapeutics
RNAC
$257M
$1.29M ﹤0.01%
32,756
+15,780
+93% +$468K
TALKW
2269
CALL
DELISTED
Talkspace Inc Warrant
TALKW
$1.28M ﹤0.01%
755,000
PEGR
2270
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$1.28M ﹤0.01%
131,466
+110,600
+530% +$1.08M
LSTR icon
2271
Landstar System
LSTR
$6.1B
$1.28M ﹤0.01%
+8,801
New +$1.31M
KRON
2272
DELISTED
Kronos Bio
KRON
$1.27M ﹤0.01%
349,052
+272,983
+359% +$1.24M
ETWO.WS
2273
CALL
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$1.27M ﹤0.01%
162,939
NKE icon
2274
Nike
NKE
$60.3B
$1.27M ﹤0.01%
12,401
-208,809
-94% -$24.7M
KLRS
2275
Kalaris Therapeutics
KLRS
$96.6M
$1.27M ﹤0.01%
14,116

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.